Differential Effects of Transforming Growth Factor-β1, a Fibrogenic Factor, on Macrophage-Like Cells (HS-P) and Myofibroblastic Cells (MT-9) In Vitro
Authors:
Open Access
- 1 June 2001
- journal article
- research article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 29 (4) , 483-491
Abstract
Transforming growth factor- β1 (TGF- β1) produced by infiltrating macrophages plays a role in fibrotic disorders through the induction of myofibroblasts. To explore possible mechanisms by which TGF- β1 may act in this context, we investigated effects of TGF- β1 on macrophage-like (HS-P) and myofibroblastic (MT-9) cells, two novel cell lines developed by us. Immunocytochemicall y, the addition of TGF- β1 (0, 0.1, 0.5, and 1.0 ng/ml) dose-dependently suppressed the expressions of antigens recognized by macrophage/histiocyte-specific antibodies (ED1 and ED2) in HS-P cells, whereas the addition concomitantly increased the number of anti- α-smooth muscle actin antibody-positive myofibroblastic cells, suggesting a possible phenotypical modulation of macrophages into myofibroblasts in the fibrotic lesions. By contrast, MT-9 cells did not show such immunophenotypica l changes following TGF- β1 addition. DNA synthesis, measured by tritiated thymidine-incorporation , was inhibited in a dose-dependen tmanner in MT-9 cells by TGF- β1 addition (0, 0.1, 0.2, 0.5, 1.0, 5, and 10 ng/ml), but that in HS-P cells was unchanged. Northern blot analysis revealed that expressions of cell cycle-related early genes, c- jun and c- myc, were increased in HS-P cells after TGF- β1 (1 ng/ml) addition, with c- jun showing peak expression prior to c- myc. By contrast, the peak expressions of c- jun and c- myc were delayed in TGF- β1 (1 ng/ml)-added MT-9 cells, and their levels were less in MT-9 cells than in HS-P cells. Furthermore, TGF- β1 (1 and 10 ng/ml) induced DNA laddering in MT-9 cells, but did not in HS-P cells. Based on these findings, it was speculated that TGF- β1 could have induced G1 arrest in cell cycle and apoptosis in MT-9 cells. The present study showed that there were significant differences in the effects of TGF- β1 between macrophage-like HS-P cells and myofibroblastic MT-9 cells, presumably depending on divergent susceptibilities to TGF- β1 between both cell types. Because such cell types are key cells in the fibrogenesis, HS-P and MT-9 might be useful models for investigating the pathogenesis of fibrosis in vitro.Keywords
This publication has 34 references indexed in Scilit:
- Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitroKidney International, 1999
- TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cellsKidney International, 1999
- Effect of Extracellular Matrix on Gene Expression and mRNA Stability in Primary Rat Hepatocytes.Journal of Toxicologic Pathology, 1998
- Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOPOncogene, 1997
- Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient MiceScience, 1996
- Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration.Molecular and Cellular Biology, 1992
- Macrophage and perisinusoidal cell kinetics in acute liver injuryThe Journal of Pathology, 1992
- Possible Derivation from Macrophages in XanthogranulomaThe American Journal of Dermatopathology, 1989
- Origin of myofibroblasts in the avascular capsule around free-floating intraperitoneal blood clotsPathology, 1983
- Cloning and characterisation of the abundant cytoplasmic 7S RNA from mouse cellsNucleic Acids Research, 1982